Axonal TDP-43 Dysregulation in ALS and Dementia
ALS 和痴呆症中的轴突 TDP-43 失调
基本信息
- 批准号:10727012
- 负责人:
- 金额:$ 40.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
TDP-43 proteinopathy is a hallmark neuropathology among an array of neurodegenerative
disorders, including ALS, FTD, and Alzheimer’s Disease to name a few. Common presentation of
TDP-43 proteinopathy includes the mislocalization of TDP-43 from the nucleus to the cytoplasm,
disrupting its known function as an RNA-binding protein (RBP). This mislocalization alters global
transcriptional dysregulation, such as the increase of cryptic exon expression, as well as effecting
local translation of RNAs. Recent studies suggests that TDP-43 is actively transported into the
axon, mediated by endolysosomal hitch-hiking on kinesin motors, which is perturbed in
neurodegenerative diseases. Moreover, the transport and axonal translation of RNA is important
for neuronal function and axon maintenance. Preliminary data from our lab and existing literature,
suggests that KIF1A might be a candidate kinesin-motor which facilitates the transport of TDP-43
into the axon. Here, we hypothesize that TDP-43 transports RNA to the axon to facilitate local
translation through KIF1A protein, which is perturbed in ALS. The resultant loss of functional TDP-
43 in the axon prevents the localization of key transcripts necessary for de novo protein synthesis
and maintenance of the axon. Downstream consequences of this pathogenic event involve the
perturbance of the axonal proteotranscriptome, loss of proteostasis, and functional deficits that
would otherwise support axon integrity.
TDP-43蛋白质病是一系列神经退行性的标志性神经病理学
包括ALS,FTD和阿尔茨海默氏病在内的疾病仅举几例。常见的表现
TDP-43蛋白质病包括从细胞核到细胞质的TDP-43错误定位,
破坏其已知功能作为RNA结合蛋白(RBP)。这种错误的定位改变了全球
转录失调,例如加密外显子表达的增加以及影响
RNA的本地翻译。最近的研究表明,TDP-43积极运输到
轴突,由内溶血式搭式式式驱动器介导,并在驱动器上受到干扰
神经退行性疾病。此外,RNA的传输和轴突翻译很重要
用于神经元功能和轴突维护。我们实验室和现有文献的初步数据,
表明KIF1A可能是候选运动动机,可促进TDP-43的运输
进入轴突。在这里,我们假设TDP-43将RNA传输到轴突以促进局部
通过KIF1A蛋白的翻译,该蛋白在ALS中受到干扰。功能性TDP的结果损失
43在轴突中阻止了从头蛋白质合成所需的关键转录本的定位
和轴突的维护。此致病事件的下游后果涉及
轴突蛋白转录组的扰动,蛋白毒酸的丧失和功能性缺陷
否则将支持轴突完整性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Christopher James ...的其他基金
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD
一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用
- 批准号:1013316410133164
- 财政年份:2018
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD
一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用
- 批准号:1037034410370344
- 财政年份:2018
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD
一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用
- 批准号:1002119110021191
- 财政年份:2018
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS
ALS 中 C9orf72 和 Matrin 3 相互作用的分子机制
- 批准号:93243879324387
- 财政年份:2017
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
相似国自然基金
大肠杆菌基因工程菌发酵生产琥珀酸过程中CO2转运与固定的协同代谢调控
- 批准号:21176059
- 批准年份:2011
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Development of an animal model to test HDAC6 as a drug target to reduce and/or prevent fetal growth restriction
开发动物模型来测试 HDAC6 作为减少和/或预防胎儿生长受限的药物靶点
- 批准号:1078582510785825
- 财政年份:2023
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
Mechanism and function of retrograde mitochondrial transport in axons
轴突逆行线粒体转运的机制和功能
- 批准号:1057095510570955
- 财政年份:2022
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
Mechanisms of A-I RNA editing-mediated nuclear export of TDP-43
A-I RNA编辑介导的TDP-43核输出机制
- 批准号:1057598410575984
- 财政年份:2022
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
How do neurons maintain mitochondrial homeostasis in vivo?
神经元如何维持体内线粒体稳态?
- 批准号:1058645010586450
- 财政年份:2022
- 资助金额:$ 40.78万$ 40.78万
- 项目类别:
How do neurons maintain mitochondrial homeostasis in vivo?
神经元如何维持体内线粒体稳态?
- 批准号:1070658710706587
- 财政年份:2022
- 资助金额:$ 40.78万$ 40.78万
- 项目类别: